Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125425321 | 12542532 | 1 | I | 20160624 | 20160709 | 20160709 | EXP | JP-CIPLA LTD.-2016JP09099 | CIPLA | 0.00 | Y | 0.00000 | 20160709 | OT | JP | JP |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125425321 | 12542532 | 1 | PS | GEMCITABINE | GEMCITABINEGEMCITABINE HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 1000 MG/M2, OVER 30 MIN ON DAYS 1 AND 8 OF A 3-WEEK CYCLE | U | U | 78759 | 1000 | MG/M**2 | ||||||
125425321 | 12542532 | 2 | SS | GEMCITABINE | GEMCITABINEGEMCITABINE HYDROCHLORIDE | 1 | Unknown | UNK | U | U | 78759 | ||||||||
125425321 | 12542532 | 3 | SS | Irinotecan | IRINOTECAN | 1 | Unknown | UNK | 0 | ||||||||||
125425321 | 12542532 | 4 | SS | OXALIPLATIN. | OXALIPLATIN | 1 | 130 MG/M2, ON DAY 1 ADMINISTERED AS A 2-H INFUSION AFTER GEMCITABINE | U | U | 0 | 130 | MG/M**2 | |||||||
125425321 | 12542532 | 5 | SS | OXALIPLATIN. | OXALIPLATIN | 1 | Unknown | UNK | U | U | 0 | ||||||||
125425321 | 12542532 | 6 | SS | ETOPOSIDE. | ETOPOSIDE | 1 | Unknown | UNK | 0 | ||||||||||
125425321 | 12542532 | 7 | SS | CISPLATIN. | CISPLATIN | 1 | Unknown | UNK | 0 | ||||||||||
125425321 | 12542532 | 8 | SS | IFOSFAMIDE. | IFOSFAMIDE | 1 | Unknown | UNK | 0 | ||||||||||
125425321 | 12542532 | 9 | SS | PACLITAXEL. | PACLITAXEL | 1 | Unknown | UNK | 0 | ||||||||||
125425321 | 12542532 | 10 | SS | Nedaplatin | NEDAPLATIN | 1 | Unknown | UNK | 0 | ||||||||||
125425321 | 12542532 | 11 | SS | BLEOMYCIN | BLEOMYCIN SULFATE | 1 | Unknown | UNK | 0 | ||||||||||
125425321 | 12542532 | 12 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | UNK | U | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125425321 | 12542532 | 1 | Testicular germ cell cancer |
125425321 | 12542532 | 3 | Testicular germ cell cancer |
125425321 | 12542532 | 4 | Testicular germ cell cancer |
125425321 | 12542532 | 6 | Testicular germ cell cancer |
125425321 | 12542532 | 7 | Testicular germ cell cancer |
125425321 | 12542532 | 8 | Testicular germ cell cancer |
125425321 | 12542532 | 9 | Testicular germ cell cancer |
125425321 | 12542532 | 10 | Testicular germ cell cancer |
125425321 | 12542532 | 11 | Testicular germ cell cancer |
125425321 | 12542532 | 12 | Antiemetic supportive care |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125425321 | 12542532 | OT |
125425321 | 12542532 | DE |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125425321 | 12542532 | Disease progression | |
125425321 | 12542532 | Refractory cancer |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |